Research output per year
Research output per year
- 15 results
Search results
-
2022
Intensive behavioural interventions based on applied behaviour analysis (ABA) for young children with autism: A cost-effectiveness analysis
Hodgson, R., Biswas, M., Palmer, S., Marshall, D., Rodgers, M., Stewart, L., Simmonds, M., Rai, D. & Le Couteur, A., 16 Aug 2022, In: PLOS one. 17, 8, 20 p., e0270833.Research output: Contribution to journal › Article › peer-review
Open Access -
2020
Interventions based on early intensive applied behaviour analysis for autistic children: A systematic review and cost-effectiveness analysis
Rodgers, M., Marshall, D., Simmonds, M., Couteur, A. L., Biswas, M., Wright, K., Rai, D., Palmer, S., Stewart, L. & Hodgson, R., Jul 2020, In: Health technology assessment (Winchester, England). 24, 35, p. 1-306 306 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
2019
Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant
Hodgson, R., O'Connor, J., Walton, M. J., Biswas, M. & Woolacott, N. F., 31 Jul 2019, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
2018
Liposomal cytarabine and daunorubicin for untreated acute myeloid leukaemia
Claxton, L., Llewellyn, A., Biswas, M., Hodgson, R., Stewart, L., Harden, M. & Wade, R., 19 Dec 2018, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
Midostaurin for untreated acute myeloid leukaemia
Hodgson, R., Biswas, M., Mebrahtu, T., Morgan, P. J., Harden, M. & Woolacott, N. F., 13 Jun 2018, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
2017
A Review of Ruxolitinib for the Treatment of Myelofibrosis: A Critique of the Evidence
Wade, R. F., Hodgson, R., Biswas, M., Harden, M. & Woolacott, N. F., Feb 2017, In: PharmacoEconomics. 35, 2, p. 203-213 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
Corbett, M., Chehadah, F., Biswas, M., Moe-Byrne, T., Palmer, S., Soares, M., Walton, M., Harden, M., Ho, P., Woolacott, N. & Bojke, L., 5 Oct 2017, In: Health technology assessment. 21, 56, p. 1-326 326 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Morgan, P. J., Woolacott, N. F., Biswas, M., Mebrahtu, T., Harden, M. & Hodgson, R., 24 Mar 2017, (E-pub ahead of print) In: PharmacoEconomics. p. 1-11 12 p.Research output: Contribution to journal › Review article
Open AccessFile -
Relationship between health-related quality of life and respiratory health status among coal-based sponge iron plant workers in Barjora, India
Biswas, M. & Chattopadhyay, K., 6 Nov 2017, In: Journal of public health. p. 1-5 5 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Ustekinumab for treating moderately to severely active CD after prior therapy
Hodgson, R., Biswas, M., Mebrahtu, T., Walton, M. J., Harden, M. & Woolacott, N. F., 12 Jul 2017, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Hodgson, R., Walton, M., Biswas, M., Mebrahtu, T. & Woolacott, N., 30 Nov 2017, (E-pub ahead of print) In: PharmacoEconomics. p. 1-12 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
2016
Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer
Hodgson, R., Biswas, M., Morgan, P. J., Mebrahtu, T., Harden, M. & Woolacott, N. F., 28 Sept 2016, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
Ruxolitinib for disease-related splenomegaly or symptoms in adults with myelofibrosis (review of TA289)
Hodgson, R., Wade, R., Biswas, M., Harden, M. & Woolacott, N. F., 23 Mar 2016, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
The healthcare costs of heart failure during the last five years of life: A retrospective cohort study
Hollingworth, W., Biswas, M., Maishman, R. L., Dayer, M. J., McDonagh, T., Purdy, S., Reeves, B. C., Rogers, C. A., Williams , R. & Pufulete, M., 1 Dec 2016, In: International Journal of Cardiology. 224, p. 132–138 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
2015
Dinutuximab for treating high-risk neuroblastoma. Evidence Review Group Report for the National Institute for Health and Care Excellence
Saramago Goncalves, P. R., Simmonds, M. C., Biswas, M., Wright, K., Woolacott, N. F. & Rothery, C., 2015, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report